{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:03:14Z","timestamp":1792004594434,"version":"4.4.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T00:00:00Z","timestamp":1393804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090374","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T21:52:58Z","timestamp":1393883578000},"page":"e90374","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins \u03b1v\u03b23 and \u03b1v\u03b25"],"prefix":"10.1371","volume":"9","author":[{"given":"Ngan Ching","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"BW Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MCP.0b013e328302851d","article-title":"Malignant mesothelioma 2008","volume":"14","author":"MD Zervos","year":"2008","journal-title":"Curr Opin Pulm Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"AS Tsao","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1073\/pnas.82.11.3884","article-title":"Asbestos-associated chromosomal changes in human mesothelial cells","volume":"82","author":"JF Lechner","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"RO Hynes","year":"2002","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/scbi.1996.0018","article-title":"The role of alpha v-integrins in tumour progression and metastasis","volume":"7","author":"JF Marshall","year":"1996","journal-title":"Semin Cancer Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/339058a0","article-title":"Induction of angiogenesis during the transition from hyperplasia to neoplasia","volume":"339","author":"J Folkman","year":"1989","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1055\/s-0037-1615250","article-title":"Role of integrin alpha(v)beta3 in vascular biology","volume":"80","author":"TV Byzova","year":"1998","journal-title":"Thromb Haemost"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","article-title":"Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels","volume":"79","author":"PC Brooks","year":"1994","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1172\/JCI118227","article-title":"Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin","volume":"96","author":"PC Brooks","year":"1995","journal-title":"J Clin Invest"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1126\/science.270.5241.1500","article-title":"Definition of two angiogenic pathways by distinct alpha v integrins","volume":"270","author":"M Friedlander","year":"1995","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nm0596-529","article-title":"Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization","volume":"2","author":"HP Hammes","year":"1996","journal-title":"Nat Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/B:AGEN.0000011801.98187.f2","article-title":"alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro","volume":"6","author":"RE Nisato","year":"2003","journal-title":"Angiogenesis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1756-9966-27-86","article-title":"Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK\/src\/AKT pathway","volume":"27","author":"L Oliveira-Ferrer","year":"2008","journal-title":"J Exp Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/ijc.24240","article-title":"Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency","volume":"124","author":"T Mikkelsen","year":"2009","journal-title":"Int J Cancer"},{"key":"ref16","first-page":"151","article-title":"Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist","volume":"48","author":"TJ MacDonald","year":"2001","journal-title":"Neurosurgery"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1200\/JCO.2006.06.6514","article-title":"Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma","volume":"25","author":"LB Nabors","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1177\/1947601912450586","article-title":"Cilengitide: a prototypic integrin inhibitor for the treatment of glioblastoma and other malignancies","volume":"2","author":"DA Reardon","year":"2011","journal-title":"Genes Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: biological implications and therapeutic opportunities","volume":"10","author":"JS Desgrosellier","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"RM Flores","year":"2007","journal-title":"J Thorac Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0046-8177(97)90284-7","article-title":"Pleural mesotheliomas have an integrin profile distinct from visceral carcinomas","volume":"28","author":"GK Koukoulis","year":"1997","journal-title":"Hum Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<1034::AID-IJC19>3.0.CO;2-4","article-title":"Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of beta1 integrins","volume":"72","author":"J Klominek","year":"1997","journal-title":"Int J Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/dc.20282","article-title":"Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping","volume":"33","author":"E Sigstad","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"HI Pass","year":"2005","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/JTO.0b013e31821e1c08","article-title":"Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma","volume":"6","author":"A Cristaudo","year":"2011","journal-title":"J Thorac Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1172\/JCI118246","article-title":"Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5","volume":"96","author":"AM Boylan","year":"1995","journal-title":"J Clin Invest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1242\/bio.2012364","article-title":"Matched rabbit monoclonal antibodies against alphav-series integrins reveal a novel alphavbeta3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors","volume":"1","author":"SL Goodman","year":"2012","journal-title":"Biol Open"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1215\/15228517-2009-012","article-title":"Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro","volume":"11","author":"GD Maurer","year":"2009","journal-title":"Neuro Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.124.4.619","article-title":"Disruption of epithelial cell-matrix interactions induces apoptosis","volume":"124","author":"SM Frisch","year":"1994","journal-title":"J Cell Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.029","article-title":"Anoikis resistance and tumor metastasis","volume":"272","author":"CD Simpson","year":"2008","journal-title":"Cancer Lett"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/path.3000","article-title":"Anoikis: an emerging hallmark in health and diseases","volume":"226","author":"ML Taddei","year":"2012","journal-title":"J Pathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e4449","DOI":"10.1371\/journal.pone.0004449","article-title":"The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells","volume":"4","author":"GC Alghisi","year":"2009","journal-title":"PLoS One"},{"key":"ref33","first-page":"1039","article-title":"The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma","volume":"19","author":"L Tentori","year":"2008","journal-title":"Oncol Rep"},{"key":"ref34","article-title":"Combination therapy of cilengitide with belotecan against experimental glioblastoma","author":"YH Kim","year":"2013","journal-title":"Int J Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2144\/000113353","article-title":"An agarose spot assay for chemotactic invasion","volume":"48","author":"H Wiggins","year":"2010","journal-title":"Biotechniques"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/bjc.2011.152","article-title":"Phase I\/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and\/or metastatic squamous cell cancer of the head and neck: findings of the phase I part","volume":"104","author":"JB Vermorken","year":"2011","journal-title":"Br J Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s10637-010-9537-9","article-title":"A phase I study of continuous infusion cilengitide in patients with solid tumors","volume":"30","author":"PH O'Donnell","year":"2012","journal-title":"Invest New Drugs"},{"key":"ref38","article-title":"Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction","author":"P Leblond","year":"2013","journal-title":"Anticancer Drugs"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<77::AID-IJC12>3.0.CO;2-7","article-title":"Pleural mesothelioma mimics the integrin profile of activated, sessile rather than detached mesothelial cells","volume":"72","author":"TF Barth","year":"1997","journal-title":"Int J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e58132","DOI":"10.1371\/journal.pone.0058132","article-title":"Phenotypes and karyotypes of human malignant mesothelioma cell lines","volume":"8","author":"V Relan","year":"2013","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0003-4975(94)90090-6","article-title":"Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma","volume":"57","author":"WR Smythe","year":"1994","journal-title":"The Annals of thoracic surgery"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T03:36:10Z","timestamp":1565235370000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090374"}},"subtitle":[],"editor":[{"given":"Lucia R.","family":"Languino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,3]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090374","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,3]]}}}